Noticias y Actividades de EyePoint Pharmaceuticals

EyePoint Pharmaceuticals es una de las ...

• Russell 3000;
• TOB Iconic 10,000.

EyePoint Pharmaceuticals es una empresa que cotiza bajo el símbolo de cotización EYPT (US).

Ver el organigrama con sus 20 ejecutivos principales

Biografías más buscadas en EyePoint Pharmaceuticals

• Jay Duker, President and Chief Executive Officer
• Nancy Lurker, Executive Vice Chairman of the Board
• Wendy DiCicco, Director

Recientes movimientos de ejecutivos en EyePoint Pharmaceuticals

• Reginald Sanders, se ha incorporado a la empresa como Director  (noticia publicada el 8 de enero de 2025).
• Said Saim, Senior Vice President and Chief Technology Officer, ha dejado la empresa  (noticia publicada el 8 de enero de 2025).
• Fred Hassan, se ha incorporado a la empresa como Director  (noticia publicada el 5 de septiembre de 2024).

Crear su alerta
para seguir los movimientos de los ejecutivos en EyePoint Pharmaceuticals.

EyePoint Pharmaceuticals tiene 1.021 competidores entre los que se incluyen Philips (Países Bajos), Medtronic (Irlanda) y Thermo Fisher Scientific (Estados Unidos).

Popular M&A news in Equipos médicos

• RadNet has announced the acquisition of Icad  (publicado el 25 de abril de 2025).
• Patient Square Capital ha Patterson Cos adquirido (publicado el 22 de abril de 2025).
• Globus Medical has announced the acquisition of Nevro  (publicado el 4 de abril de 2025).

Otros contactos sugeridos en el sector Equipos médicos

• Shruthi Narayan - Executive Vice President and General Manager, Interventional en Penumbra
• Christian Pawlu - Head of Corporate Development en Fresenius SE
• Volker Wetekam - Director en Elekta Instrument

Saber más sobre el sector Equipos médicos

Últimos comunicados de prensa de EyePoint Pharmaceuticals

• EyePoint to Report First Quarter 2025 Financial Results on May 7, 2025 - EyePoint Pharmaceuticals
• EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - EyePoint Pharmaceuticals
• In The News – EyePoint
• VIDEO: Duravyu for wet AMD shows similar outcomes to aflibercept
• News & Resources – EyePoint
• Press Releases – EyePoint
• EyePoint to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference | EyePoint Pharmaceuticals
• EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | EyePoint Pharmaceuticals
• EyePoint Announces Participation at Upcoming Investor Conferences | EyePoint Pharmaceuticals
• EyePoint Reports Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Developments | EyePoint Pharmaceuticals
• View more press releases Close

Redes sociales sobre EyePoint Pharmaceuticals

• EyePoint Pharmaceuticals en Wikipedia, Google News y Yahoo Finance
• EyePoint Pharmaceuticals en LinkedIn, Twitter y YouTube